Generics
Dosage form development |
|
| The current formulation development team has the capability to bring to market over 40 new products every year, products that are bioequivalent to internationally available brands. This expertise spans immediate/controlled release products as well as complex injectables and differentiated delivery systems. Simpler dosage forms handled include tablets, capsules, liquids, and ointments. Complex products include soft gel caps, liposome targeted drug delivery, osmotic delivery systems, inclusion complexes, meltabs, transdermals, aerosols, biodegradable depot-based formulations for 1 month/3 month release. |
|
| Dedicated labs for formulation development are similar to facilities at the plants and this facilitates easier scale up. |
|
| Facilities |
 | Solid oral dosage form labs |
| Semisolid lab |
| Nanotechnology/liposome lab |
| Sterile lab for parenterals |
| Aerosol area |
| Packaging development lab |
| Stability testing labs |
|
|
|
|
 |
|
|
|
|
|
|
|
